Silver_ nanoparticles inhibited erythrogenesis during zebrafish embryogenesis

Area of Science:

• Environmental toxicology
• Developmental biology
• Nanomaterial safety

Background:

• Silver nanoparticles (AgNPs) are widely used for their antimicrobial properties.
• AgNPs exhibit toxicity to blood cells in aquatic organisms and humans.
• Limited in vivo studies exist on AgNP effects on hematopoiesis.

Purpose of the Study:

• To investigate the toxic effects of AgNPs on hematopoiesis in zebrafish embryos.
• To elucidate the mechanisms underlying AgNP-induced hematotoxicity.
• To determine whether AgNP toxicity is mediated by particles or released ions.

Main Methods:

• Transcriptional profiling using microarrays in zebrafish embryos exposed to AgNPs at 24 hours post-fertilization (hpf).
• Quantitative real-time PCR (qRT-PCR), whole-mount in situ hybridization, and O-dianisidine staining to validate gene expression.
• Analysis of mesoderm commitment, hematopoietic progenitor cell specification, and erythroid differentiation at various developmental stages.

Main Results:

• AgNPs significantly down-regulated hemoglobin genes, confirmed across multiple validation methods.
• Gene Ontology (GO) analysis indicated enrichment of hemoglobin-related categories.
• AgNPs inhibited erythrogenesis in a developmental-stage-specific and cell-specific manner.

Conclusions:

• AgNPs interfere with zebrafish embryo erythrogenesis, impacting hematopoiesis.
• The primary mechanism of AgNP toxicity on erythrogenesis involves the nanoparticles themselves, rather than their released ions.
• Further research is warranted to understand the full toxicological profile of AgNPs in vivo.